The MarketReader Minute
π Immutep Surges on Trial Success, Biogen Dips on Legal Woes, Regeneron Hits High, AbbVie Expands Portfolio | Biotech Sector Insights
Regeneron Pharmaceuticals (REGN) reached an all-time high, supported by a positive analyst outlook. The US Michigan Consumer Sentiment Prel data showed mixed results compared to expectations but indicated improving trends that could influence IBB's volatility.